nach oben

Erschienen in:

13.07.2021 | Original Article

Orthostatic hypotension in patients with Alzheimer’s disease: a meta-analysis of prospective studies

verfasst von: Ahmet Turan Isik, Neziha Erken, Idil Yavuz, Derya Kaya, Mehmet Selman Ontan, Esra Ates Bulut, Fatma Sena Dost

Erschienen in: Neurological Sciences | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Background

Orthostatic hypotension (OH) is a clinical sign associated with severe adverse health outcomes in older adults. It has been reported to be common in patients with Alzheimer’s disease (AD). The present meta-analysis aimed to investigate the prevalence and risk of OH in AD patients.

Methods

English-language articles published from January 1990 to August 2020 were searched in PubMed, ScienceDirect, Cochrane, and Web of Science with the keywords “Alzheimer” and “autonomic dysfunction” or “dysautonomia” or “postural hypotension” or “orthostatic hypotension.” All prospective clinical studies (case–control, cohort, and cross-sectional studies, and randomized controlled trials) that were regarded as pertinent were included in this study. For quality assessment, the Newcastle–Ottawa Scale was used. Odds ratios (OR) and risk ratios (RR) were extracted with 95% confidence intervals (CI) and combined using the random effects model after logarithmic transformation. The prevalence in the AD patients was also combined using the random effects model.

Results

The meta-analysis involved 11 studies (7 case–control and 4 case series) to assess the risk of OH in AD. It was found that AD increased the risk of OH with an RR of 1.98 (95% CI: 0.97–4.04) and an OR of 2.53 (95% CI:1.10–5.86) compared to healthy controls, and OH was present in 28% (95% CI: 0.17–0.40) of 500 AD patients.

Conclusion

There is an elevated risk of OH in AD by nearly 2.5-fold. Therefore, the evaluation of postural blood pressure changes should definitely be among the follow-up and treatment goals of AD.

Nur mit Berechtigung zugänglich

Lahrmann H, Cortelli P, Hilz M, Mathias CJ, Struhal W, Tassinari M (2006) EFNS guidelines on the diagnosis and management of orthostatic hypotension. Eur J Neurol 13(9):930–936. https://doi.org/10.1111/j.1468-1331.2006.01512.xCrossRefPubMed

Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, Cheshire WP, Chelimsky T, Cortelli P, Gibbons CH, Goldstein DS, Hainsworth R, Hilz MJ, Jacob G, Kaufmann H, Jordan J, Lipsitz LA, Levine BD, Low PA, Mathias C, Raj SR, Robertson D, Sandroni P, Schatz I, Schondorff R, Stewart JM, van Dijk JG (2011) Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res 21(2):69–72. https://doi.org/10.1007/s10286-011-0119-5CrossRefPubMed

Ricci F, De Caterina R, Fedorowski A (2015) Orthostatic hypotension: epidemiology, prognosis, and treatment. J Am Coll Cardiol 66(7):848–860. https://doi.org/10.1016/j.jacc.2015.06.1084CrossRefPubMed

Mol A, Bui Hoang PTS, Sharmin S, Reijnierse EM, van Wezel RJA, Meskers CGM, Maier AB (2019) Orthostatic hypotension and falls in older adults: a systematic review and meta-analysis. J Am Med Dir Assoc 20(5):589-597.e585. https://doi.org/10.1016/j.jamda.2018.11.003CrossRefPubMed

Brown WR, Thore CR (2011) Review: cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol Appl Neurobiol 37(1):56–74. https://doi.org/10.1111/j.1365-2990.2010.01139.xCrossRefPubMedPubMedCentral

Mu F, Jiao Q, Du X, Jiang H (2020) Association of orthostatic hypotension with Parkinson’s disease: a meta-analysis. Neurol Sci 41(6):1419–1426. https://doi.org/10.1007/s10072-020-04277-wCrossRefPubMed

Soysal P, Veronese N, Smith L, Torbahn G, Jackson SE, Yang L, Ungar A, Rivasi G, Rafanelli M, Petrovic M (2019) Orthostatic hypotension and health outcomes: an umbrella review of observational studies. Eur Geriatr Med 10(6):863–870CrossRefPubMed

Cremer A, Soumaré A, Berr C, Dartigues JF, Gabelle A, Gosse P, Tzourio C (2017) Orthostatic Hypotension and Risk of Incident Dementia: Results From a 12-Year Follow-up of the three-city study cohort. Hypertension 70(1):44–49. https://doi.org/10.1161/hypertensionaha.117.09048CrossRefPubMed

Isik AT, Kocyigit SE, Smith L, Aydin AE, Soysal P (2019) A comparison of the prevalence of orthostatic hypotension between older patients with Alzheimer’s disease, Lewy body dementia, and without dementia. Exp Gerontol 124:110628. https://doi.org/10.1016/j.exger.2019.06.001CrossRefPubMed

10.

Rüb U, Del Tredici K, Schultz C, Thal DR, Braak E, Braak H (2001) The autonomic higher order processing nuclei of the lower brain stem are among the early targets of the Alzheimer’s disease-related cytoskeletal pathology. Acta neuropathologica 101(6):555–564. https://doi.org/10.1007/s004010000320CrossRefPubMed

11.

Tulbă D, Cozma L, Popescu BO, Davidescu EI (2020) Dysautonomia in Alzheimer's disease. Medicina (Kaunas, Lithuania) 56 (7). doi:https://doi.org/10.3390/medicina56070337

12.

Joseph A, Wanono R, Flamant M, Vidal-Petiot E (2017) Orthostatic hypotension: a review. Nephrologie Therapeutique 13(Suppl 1):S55-s67. https://doi.org/10.1016/j.nephro.2017.01.003CrossRefPubMed

13.

Jensen-Dahm C, Waldemar G, Staehelin Jensen T, Malmqvist L, Moeller MM, Andersen BB, Høgh P, Ballegaard M (2015) Autonomic dysfunction in patients with mild to moderate Alzheimer’s disease. J Alzheimers Dis 47(3):681–689. https://doi.org/10.3233/jad-150169CrossRefPubMed

14.

Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097. https://doi.org/10.1371/journal.pmed.1000097CrossRefPubMedPubMedCentral

15.

McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheim Dement 7(3):263–269. https://doi.org/10.1016/j.jalz.2011.03.005CrossRef

16.

Parry SW, Reeve P, Lawson J, Shaw FE, Davison J, Norton M, Frearson R, Kerr S, Newton JL (2009) The Newcastle protocols 2008: an update on head-up tilt table testing and the management of vasovagal syncope and related disorders. Heart 95(5):416–420. https://doi.org/10.1136/hrt.2007.136457CrossRefPubMed

17.

Shibao C, Lipsitz LA, Biaggioni I (2013) Evaluation and treatment of orthostatic hypotension. J Am Soc Hypertens 7(4):317–324. https://doi.org/10.1016/j.jash.2013.04.006CrossRefPubMedPubMedCentral

18.

Wells G, Shea B, O’Connell D, J Peterson, V Welch, M Losos, Tugwell. P (2012) The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. http//www.ohri.ca/ programs/clinical epidemiology/oxford.asp.

19.

Kim JS, Park HE, Oh YS, Song IU, Yang DW, Park JW, Lee KS (2015) (123)I-MIBG myocardial scintigraphy and neurocirculatory abnormalities in patients with dementia with Lewy bodies and Alzheimer’s disease. J Neurol Sci 357(1–2):173–177. https://doi.org/10.1016/j.jns.2015.07.025CrossRefPubMed

20.

Siennicki-Lantz A, Lilja B, Elmståhl S (1999) Orthostatic hypotension in Alzheimer’s disease: result or cause of brain dysfunction? Aging 11(3):155–160PubMed

21.

Allan LM, Ballard CG, Allen J, Murray A, Davidson AW, McKeith IG, Kenny RA (2007) Autonomic dysfunction in dementia. J Neurol Neurosurg Psychiatry 78(7):671–677. https://doi.org/10.1136/jnnp.2006.102343CrossRefPubMed

22.

Allan LM, Ballard CG, Rowan EN, Kenny RA (2009) Incidence and prediction of falls in dementia: a prospective study in older people. PloS one 4(5):e5521. https://doi.org/10.1371/journal.pone.0005521CrossRefPubMedPubMedCentral

23.

Burton EJ, McKeith IG, Burn DJ, Firbank MJ, O’Brien JT (2006) Progression of white matter hyperintensities in Alzheimer disease, dementia with lewy bodies, and Parkinson disease dementia: a comparison with normal aging. Am J Geriatr Psychiatry 14(10):842–849. https://doi.org/10.1097/01.JGP.0000236596.56982.1cCrossRefPubMed

24.

Vitiello B, Veith RC, Molchan SE, Martinez RA, Lawlor BA, Radcliffe J, Hill JL, Sunderland T (1993) Autonomic dysfunction in patients with dementia of the Alzheimer type. Biol Psychiatry 34(7):428–433. https://doi.org/10.1016/0006-3223(93)90233-4CrossRefPubMed

25.

Zakrzewska-Pniewska B, Gawel M, Szmidt-Salkowska E, Kepczynska K, Nojszewska M (2012) Clinical and functional assessment of dysautonomia and its correlation in Alzheimer’s disease. Am J Alzheimers Dis Other Dement 27(8):592–599. https://doi.org/10.1177/1533317512459792CrossRef

26.

Ballard C, Shaw F, McKeith I, Kenny R (1998) High prevalence of neurovascular instability in neurodegenerative dementias. Neurology 51(6):1760–1762. https://doi.org/10.1212/wnl.51.6.1760CrossRefPubMed

27.

Passant U, Warkentin S, Karlson S, Nilsson K, Edvinsson L, Gustafson L (1996) Orthostatic hypotension in organic dementia: relationship between blood pressure, cortical blood flow and symptoms. Clin Auton Res 6(1):29–36. https://doi.org/10.1007/bf02291403CrossRefPubMed

28.

Isik AT, Soysal P, Usarel C (2016) Effects of Acetylcholinesterase Inhibitors on Balance and Gait Functions and Orthostatic Hypotension in Elderly Patients With Alzheimer Disease. Am J Alzheimers Dis Other Dement 31(7):580–584. https://doi.org/10.1177/1533317516666195CrossRef

29.

Swaab DF, Raadsheer FC, Endert E, Hofman MA, Kamphorst W, Ravid R (1994) Increased cortisol levels in aging and Alzheimer’s disease in postmortem cerebrospinal fluid. J Neuroendocrinol 6(6):681–687. https://doi.org/10.1111/j.1365-2826.1994.tb00635.xCrossRefPubMed

30.

Brureau A, Zussy C, Delair B, Ogier C, Ixart G, Maurice T, Givalois L (2013) Deregulation of hypothalamic-pituitary-adrenal axis functions in an Alzheimer’s disease rat model. Neurobiol Aging 34(5):1426–1439. https://doi.org/10.1016/j.neurobiolaging.2012.11.015CrossRefPubMed

31.

Pascualy M, Petrie EC, Brodkin K, Peskind ER, Wilkinson CW, Raskind MA (2000) Hypothalamic pituitary adrenocortical and sympathetic nervous system responses to the cold pressor test in Alzheimer’s disease. Biol Psychiatry 48(3):247–254. https://doi.org/10.1016/s0006-3223(00)00879-9CrossRefPubMed

32.

Royall DR, Gao JH, Kellogg DL Jr (2006) Insular Alzheimer’s disease pathology as a cause of “age-related” autonomic dysfunction and mortality in the non-demented elderly. Med Hypotheses 67(4):747–758. https://doi.org/10.1016/j.mehy.2005.10.036CrossRefPubMed

33.

Braak H, Braak E (1995) Staging of Alzheimer’s disease-related neurofibrillary changes. Neurobiol Aging 16(3):271–278. https://doi.org/10.1016/0197-4580(95)00021-6CrossRefPubMed

34.

Femminella GD, Rengo G, Komici K, Iacotucci P, Petraglia L, Pagano G, de Lucia C, Canonico V, Bonaduce D, Leosco D, Ferrara N (2014) Autonomic dysfunction in Alzheimer’s disease: tools for assessment and review of the literature. J Alzheimers Dis 42(2):369–377. https://doi.org/10.3233/jad-140513CrossRefPubMed

35.

Feldstein C, Weder AB (2012) Orthostatic hypotension: a common, serious and underrecognized problem in hospitalized patients. J Am Soc Hypertens 6(1):27–39. https://doi.org/10.1016/j.jash.2011.08.008CrossRefPubMed

36.

Van Beek AH, Claassen JA (2011) The cerebrovascular role of the cholinergic neural system in Alzheimer’s disease. Behav Brain Res 221(2):537–542. https://doi.org/10.1016/j.bbr.2009.12.047CrossRefPubMed

37.

Tong XK, Hamel E (1999) Regional cholinergic denervation of cortical microvessels and nitric oxide synthase-containing neurons in Alzheimer’s disease. Neuroscience 92(1):163–175. https://doi.org/10.1016/s0306-4522(98)00750-7CrossRefPubMed

38.

Cai Z, Wan C-Q, Ke Z, Chen Y (2018) Orthostatic Hypotension in Alzheimer’s disease: A Meta-Analysis. Neuropsychiatry 8(5):1655–1660CrossRef

39.

Freidenberg DL, Shaffer LE, Macalester S, Fannin EA (2013) Orthostatic hypotension in patients with dementia: clinical features and response to treatment. Cogn Behav Neurol 26(3):105–120. https://doi.org/10.1097/wnn.0000000000000003CrossRefPubMed

40.

Sambati L, Calandra-Buonaura G, Poda R, Guaraldi P, Cortelli P (2014) Orthostatic hypotension and cognitive impairment: a dangerous association? Neurol Sci 35(6):951–957. https://doi.org/10.1007/s10072-014-1686-8CrossRefPubMed

Titel: Orthostatic hypotension in patients with Alzheimer’s disease: a meta-analysis of prospective studies
verfasst von: Ahmet Turan Isik
Neziha Erken
Idil Yavuz
Derya Kaya
Mehmet Selman Ontan
Esra Ates Bulut
Fatma Sena Dost
Publikationsdatum: 13.07.2021
Verlag: Springer International Publishing
Erschienen in: Neurological Sciences / Ausgabe 2/2022
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-021-05450-5

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2022

The role of the Sapienza GLObal Bedside Evaluation of Swallowing after Stroke (GLOBE-3S) in the prevention of stroke-associated pneumonia (SAP)

Disease severity and response to treatment in Iranian patients with myasthenia gravis

Higher incidence of cervical spinal cord compression in amyotrophic lateral sclerosis: a single-institute cohort study

Study on potential differentially expressed genes in stroke by bioinformatics analysis

Chinese abnormal compound heterozygote spinocerebellar ataxia type 8: a case report